Polydeoxyribonucleotide Treatment in Genital Lichen Sclerosus in Males.
Urol Int
; 98(1): 111, 2017.
Article
en En
| MEDLINE
| ID: mdl-27618566
ABSTRACT
It has been reported that treatment with polydeoxyribonucleotide (PDRN) in males affected by lichen sclerosus significantly improves the overall conditions of treated patients. It confirms that PDRN has a potent cytoprotective action as in other pathological conditions. We believe that multicentric randomized clinical trials are necessary for testing the benefits of this promising agent.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Polidesoxirribonucleótidos
/
Liquen Escleroso y Atrófico
Tipo de estudio:
Clinical_trials
Límite:
Humans
/
Male
Idioma:
En
Revista:
Urol Int
Año:
2017
Tipo del documento:
Article
País de afiliación:
Italia